AIM: To evaluate the diagnostic performance of parametric imaging with contrast-enhanced ultrasound(CEUS) for differentiating hepatocellular carcinoma(HCC) from metastatic liver cancer(MLC).
METHODS: 30 HCCs (mean diameter, 3.6±1.3 cm; range, 2.1–5.0 cm) and 30 MLCs (mean diameter, 2.8±1.5 cm; range, 1.2–5.0 cm) pathologically diagnosed or confirmed by clinical criteria that underwent CEUS were randomly included. CEUS was carried out using a multifrequency transducer (2–4 MHz) and a bolus injection of 2.4 mL SonoVue. The CEUS clips of the targeted lesion were recorded continuously for 6 minutes. By analyzing CEUS clips, parametric image could be obtained using the SonoLiver® software automatically. Quantitative parameters were compared between HCC and MLC groups. Receiver operating characteristic (ROC) curve analysis was further performed on parameters with significant difference between two groups.
RESULTS: On parametric imaging, the maximum intensity, rise time, time to peak, mean transit time and washout time for HCC and MLC were 185.6±148.0 vs. 95.2±58.6 (P = 0.003), 25.7±6.3 s vs. 23.8±8.8 s (P = 0.341), 30.7±7.9 s vs. 27.8±10.5 s (P = 0.246), 90.2±45.7 s vs. 89.3±40.3 s (P = 0.805), 63.4±29.5 s vs. 37.2±33.8 s (P = 0.005), respectively. ROC analysis was further performed for washout time and it showed a cut-off point of 43.765 s for the differentiation between HCC and MLC, with the AUC value of 0.780 (95% CI: 0.646–0.914). The corresponding diagnostic specificity, sensitivity and accuracy were 72.0%, 84.6% and 78.4% respectively.
CONCLUSIONS: Parametric imaging of CEUS can display perfusion effects of HCC and MLC objectively and visually and washout time may serve as a useful parameter on the differential diagnosis between HCC and MLC.
AlbrechtT., BlomleyM.J., BurnsP.N., WilsonS., HarveyC.J., LeenE., et al., Improved detection of hepatic metastases with pulse-inversion US during the liver-specific phase of SHU 508A: Multicenter study, Radiology227(2) (2003), 361–370.
2.
AlbrechtT., HoffmannC.W., SchmitzS.A., SchettlerS., OverbergA., GermerC.T., et al., Phase-inversion sonography during the liver-specific late phase of contrast enhancement: Improved detection of liver metastases, AJR Am J Roentgenol176(5) (2001), 1191–1198.
3.
AlzaraaA., GravanteG., ChungW.Y., Al-LeswasD., MorganB., DennisonA., et al., Contrast-enhanced ultrasound in the preoperative, intraoperative and postoperative assessment of liver lesions, Hepatol Res43(8) (2013), 809–819.
4.
AnayeA., PerrenoudG., RogninN., ArditiM., MercierL., FrinkingP., et al., Differentiation of focal liver lesions: Usefulness of parametric imaging with contrast-enhanced US, Radiology261(1) (2011), 300–310.
5.
BhayanaD., KimT.K., JangH.J., BurnsP.N. and WilsonS.R., Hypervascular liver masses on contrast-enhanced ultrasound: The importance of washout, Am J Roentgenol194(4) (2010), 977–983.
6.
BruixJ. and ShermanM., Management of hepatocellular carcinoma, Hepatology42(5) (2005), 1208–1236.
7.
ChiappaA, BertaniE, ZbarAP, FoschiD, FazioN, ZampinoM., et al., Optimizing treatment of hepatic metastases from colorectal cancer: Resection or resection plus ablation?Int J Oncol48(3) (2016), 1280–1289.
8.
ChioreanL., CaraianiC., RadziņaM., JedrzejczykM, Schreiber-DietrichD and DietrichC.F, Vascular phases in imaging and their role in focal liver lesions assessment, Clin Hemorheol Microcirc (2015). DOI: 10.3233/CH-151971
9.
ChoiB.I., TakayasuK. and HanM.C., Small hepatocellular carcinomas and associated nodular lesions of the liver: Pathology, pathogenesis, and imaging findings, AJR Am J Roentgenol160(6) (1993), 1177–1187.
10.
ClaudonM., DietrichC.F., ChoiB.I., CosgroveD.O., KudoM., NolsøeC.P., et al., Guidelines and Good Clinical Practice Recommendations for Contrast Enhanced Ultrasound(CEUS) in the Liver - Update AWFUMB-EFSUMB Initiative in Cooperation With Representatives of AFSUMB, AIUM, ASUM, FLAUS and ICUS, Ultraschall Med34(1) (2013), 11–29.
11.
ClevertD.A., D’AnastasiM. and JungE.M., Contrast-enhanced ultrasound and microcirculation: Efficiency through dynamics–current developments, Clin Hemorheol Microcirc53(1-2) (2013), 171–186.
12.
DietrichC.F., AverkiouM.A., CorreasJ.M., LassauN., LeenE. and PiscagliaF., An EFSUMB introduction into Dynamic Contrast-Enhanced Ultrasound (DCE-US) for quantification of tumour perfusion, Ultraschall Med33(4) (2012), 344–351.
13.
European Association For The Study Of The Liver European Organisation For Research And Treatment Of Cancer, EASL-EORTC clinical practice guidelines: Management of hepatocellular carcinoma, J Hepatol56(4) (2012), 908–943.
14.
GreisC., Technical aspects of contrast-enhanced ultrasound (CEUS) examinations: Tips and tricks, Clin Hemorheol Microcirc58 (2014), 89–95.
15.
JungE.M., ClevertD.A., SchreyerA.G., SchmittS., RennertJ., KubaleR., et al., Evaluation of quantitative contrast harmonic imaging to assess malignancy of liver tumors: A prospective controlled two-center study, World J Gastroenterol13(47) (2007), 6356–6364.
16.
KimT.K. and JangH.J., Contrast-enhanced ultrasound in the diagnosis of nodules in liver cirrhosis, World J Gastroenterol20(13) (2014), 3590–3596.
17.
KitajimaK., KuwataY., HayashiM., ImanakaK., KajiY. and SugimuraK., Ring enhancement on T1- weighted GRE images after ferucarbotran administration for hepatic metastasis: Comparison with pathological findings:case report, Radiat Med23(1) (2005), 75–79.
18.
KumadaT., NakanoS., TakedaI., SugiyamaK., OsadaT., KiriyamaS., et al., Patterns of recurrence after initial treatment in patients with small hepatocellular carcinoma, Hepatology25(1) (1997), 87–92.
19.
LarsenL.P., RosenkildeM., ChristensenH., BangN., BolvigL., ChristiansenT., et al., The value of contrast enhanced ultrasonography in detection of liver metastases from colorectal cancer: A prospective double-blinded study, Eur J Radiol62(2) (2007), 302–307.
20.
LiW., WangW., LiuG.J., ChenL.D., WangZ., HuangY., et al., Differentiation of atypical hepatocellular carcinoma from focal nodular hyperplasia: Diagnostic performance of contrast-enhanced US and microflow imaging, Radiology275(3) (2015), 870–879.
21.
LossM., SchneiderJ., UllerW., WiggermannP., SchererM.N., JungW., et al., Intraoperative high resolution linear contrast enhanced ultrasound (IOUS) for detection of microvascularization of malignant liver lesions before surgery or radiofrequeny ablation, Clin Hemorheol Microcirc50(1-2) (2012), 65–77.
22.
Piperno-NeumannS., ServoisV., MarianiP., PlancherC., Lévy-GabrielC., Lumbroso-Le RouicL., et al., Prospective study of surveillance testing for metastasis in 100 high-risk uveal melanoma patients, J Fr Ophtalmol38(6) (2015), 526–534.
23.
SakamotoM., HirohashiS. and ShimosatoY., Early stages of multistep hepatocarcinogenesis: Adenomatous hyperplasia and early hepatocellular carcinoma, Hum Pathol22(2) (1991), 172–178.
24.
SchachererD., GirlichC., WiestR., BüttnerR., SchölmerichJ., FeuerbachS., et al., Semiquantitative characterization of hepatocellular carcinoma (HCC) –perfusion with contrast-enhanced ultrasound and perfusion analysis, Clin Hemorheol Microcirc44(2) (2010), 97–105.
25.
StrobelD., SeitzK., BlankW., SchulerA., DietrichC., von HerbayA., et al., Contrast-enhanced ultrasound for the characterization of focal liver lesions–diagnostic accuracy in clinical practice (DEGUM multicenter trial), Ultraschall Med29(5) (2008), 499–505.
26.
WestwoodM., JooreM., GruttersJ., RedekopK., ArmstrongN., LeeK., et al., Contrast-enhanced ultrasound using SonoVue® (sulphur hexafluoride microbubbles) compared with contrast-enhanced computed tomography and contrast-enhanced magnetic resonance imaging for the characterization of focal liver lesions and detection of liver metastases: A systematic review and cost-effectiveness analysis, Health Technol Assess17(16) (2013), 1–243.
27.
WiggermannP., WohlgemuthW.A., HeiblM., VasiljA., LossM., SchreyerA.G., et al., Dynamic evaluation and quantification of microvascularization during degradable starch microspheres transarterial Chemoembolisation (DSM-TACE) of HCC lesions using contrast enhanced ultrasound (CEUS): A feasibility study, Clin Hemorheol Microcirc53(4) (2013), 337–348.
28.
XiaY., JiangY.X., DaiQ., XiaoY., LvK. and WangL., Contrast-enhanced ultrasound of hepatocellular carcinoma: Correlation of washout time and angiogenesis, Clin Hemorheol Microcirc48(4) (2011), 265–273.
29.
ZhengS.G., XuH.X., LiuL.N., WangY., ZhangY.F., GuoL.H., et al., Parametric imaging with contrast-enhanced ultrasound: Usefulness for characterization of dynamic effects of microvascularization for hepatocellular carcinoma and focal nodular hyperplasia, Clin Hemorheol Microcirc55(3) (2013), 375–389.
